gliclazide has been researched along with hypericum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Day, RO; Liauw, WS; McLachlan, AJ; Murray, M; Williams, KM; Xu, H | 1 |
| Abd El Aleem, DI; Abd El Motteleb, DM | 1 |
1 trial(s) available for gliclazide and hypericum
| Article | Year |
|---|---|
Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide.
Topics: Adult; Alleles; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Blood Glucose; Cross-Over Studies; Cytochrome P-450 CYP2C9; Female; Genotype; Gliclazide; Half-Life; Herb-Drug Interactions; Humans; Hypericum; Hypoglycemic Agents; Insulin; Male; Plant Extracts; Polymerase Chain Reaction; Restriction Mapping | 2008 |
1 other study(ies) available for gliclazide and hypericum
| Article | Year |
|---|---|
Renoprotective effect of Hypericum perforatum against diabetic nephropathy in rats: Insights in the underlying mechanisms.
Topics: Animals; Antioxidants; Apoptosis; Body Weight; Collagen Type IV; Cyclooxygenase 2; Cytoprotection; Diabetic Nephropathies; Fibronectins; Gene Expression Regulation, Enzymologic; Gliclazide; Hypericum; Inflammation Mediators; Kidney; Male; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; PPAR gamma; Rats; Rats, Wistar; Transforming Growth Factor beta | 2017 |